Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716050 · ClinicalTrials.gov registry record · Phase 2
The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems
A Phase 2 study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT03716050 is a Phase 2 study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 17 participants.
The verdict
NCT03716050, a Phase 2 study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a randomized study using a variety of techniques to compare and examine blood flow to the remaining skin after mastectomy. All treatments being used are considered standard of care and are not experimental. The objective is to compare the techniques and the incidence of perfusion related problems in patient's undergoing mastectomy with immediate breast reconstruction.
Interventions
- OTHER No treatment
- DRUG Nitroglycerin
- DEVICE Negative Pressure Wound Therapy/ Wound VAC
- OTHER Fluorescent Angiography with indocyanine-green (not to exceed 5mg/kg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2019-03-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03716050
The ClinicalTrials.gov registry entry for NCT03716050 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which No treatment is the first listed.
NCT03716050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03716050 about?
NCT03716050 is a clinical study titled "The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems". This is a randomized study using a variety of techniques to compare and examine blood flow to the remaining skin after mastectomy. All treatments being used are considered standard of care and are not experimental. The objective is to compare the techniques and the incidence of perfusion related pro...
What is the current status of trial NCT03716050?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2018-01-30. Estimated completion is 2019-03-12.
What interventions are being tested in trial NCT03716050?
The interventions under investigation include: No treatment (OTHER), Nitroglycerin (DRUG), Negative Pressure Wound Therapy/ Wound VAC (DEVICE), Fluorescent Angiography with indocyanine-green (not to exceed 5mg/kg) (OTHER).
Who is sponsoring clinical trial NCT03716050?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.